|
ANP32B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.04940000023035E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.60183019363103E-12 |
| Normal-vs-Stage2 |
1.055780E-01 |
| Normal-vs-Stage3 |
7.076600E-03 |
| Normal-vs-Stage4 |
8.663400E-03 |
| Stage1-vs-Stage2 |
2.196000E-03 |
| Stage1-vs-Stage3 |
1.520540E-03 |
| Stage1-vs-Stage4 |
1.077450E-01 |
| Stage2-vs-Stage3 |
5.869600E-01 |
| Stage2-vs-Stage4 |
3.186800E-01 |
| Stage3-vs-Stage4 |
5.594200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.70199995711096E-09 |
| Normal-vs-AfricanAmerican |
2.066400E-01 |
| Normal-vs-Asian |
2.149000E-01 |
| Caucasian-vs-AfricanAmerican |
1.732020E-02 |
| Caucasian-vs-Asian |
7.001800E-01 |
| AfricanAmerican-vs-Asian |
1.943950E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.94199999981448E-07 |
| Normal-vs-Female |
1.89009999873591E-08 |
| Male-vs-Female |
2.464400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.841600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.33779999972528E-07 |
| Normal-vs-Age(61-80Yrs) |
3.82700000023384E-07 |
| Normal-vs-Age(81-100Yrs) |
4.079800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.919170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.951600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.557700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.798800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.950980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.073000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.179600E-03 |
| Normal-vs-Grade 2 |
8.61533067109121E-13 |
| Normal-vs-Grade 3 |
7.627200E-04 |
| Normal-vs-Grade 4 |
9.910300E-02 |
| Grade 1-vs-Grade 2 |
3.721200E-01 |
| Grade 1-vs-Grade 3 |
2.782400E-02 |
| Grade 1-vs-Grade 4 |
9.082200E-02 |
| Grade 2-vs-Grade 3 |
6.15859999999468E-05 |
| Grade 2-vs-Grade 4 |
1.350190E-02 |
| Grade 3-vs-Grade 4 |
7.680000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
7.330400E-02 |
| ccA subtype-vs-ccB subtype |
5.52713430579388E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.28049999998026E-06 |
| Normal-vs-N1 |
2.019400E-01 |
| N0-vs-N1 |
7.477800E-01 |
|
|
